ArticlebioRxiv : the preprint server for biology2026
Gateway analysis reveals transient molecular programs at cell-fate transitions.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Single-cell atlases have transformed our view of cell identity, but they still struggle to resolve the transient states that accompany cell-fate change. These rare interface cells are outnumbered by the stable populations on either side. As a result, the molecular programs that accompany lineage transitions are hard to detect. We developed gateway analysis, a framework that identifies cells at fate boundaries and pinpoints bell and valley genes that peak or dip there. It defines cell neighborhoods from binary mutual information (BMI) in gene on/off patterns and preserves that structure in a regularized latent model. Across four single-cell atlases spanning reprogramming, gastrulation, pancreatic endocrinogenesis, and kidney injury (3,696-126,578 cells), gateway analysis recovered rare boundary populations and the transient gene programs that distinguish them from their flanking states. These signals were missed by standard comparisons of stable endpoint states. They included epithelial remodeling at the late MET-to-iPSC interface, a gate-versus-basin partition of gastrulation regulators, a transient Cck-enriched peak at endocrine hub entry together with a candidate BH4-associated signal at a shared endocrine hilltop, and a proteostasis program at the kidney injury boundary. Orthogonal support from optimal-transport fate probabilities, known markers, and published perturbation phenotypes indicate that gateway cells mark bona fide biological transition intervals. Gateway analysis therefore provides a practical framework for detecting rare transition-state cells and the bell/valley genes that define them in single-cell atlases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.